ABHISHEK GUPTA
Lawrenceville,NJ
Summary
CAREER SNAPSHOT
Analytical and results-driven finance executive with extensive leadership experience in global financial planning, operational finance, and strategic decision-making within the pharmaceutical, consumer goods, and telecom industries. Track record of managing large-scale financial operations, including forecasting, commercial launches and cost management for portfolios exceeding $1.7B. Demonstrated ability to lead high-impact projects, mentor junior professionals, and collaborate with cross-functional stakeholders to achieve business objectives. Notable for making commercial markets, launch ready for Cell-Therapy assets.Awards include Innovation, Urgency, and Leadership recognitions, underscoring a career committed to operational excellence and value creation.
Overview
18
18
years of professional experience
Work History
Associate Finance Director, Lead
Bristol Myers Squibb
, New Jersey
04.2024 - Current
- Manage cost base of ~$1.7B, by monitoring inventory write-offs, start-up costs and spending
- Lead financial month close by driving accountability with sites and present key insights to Biol leadership team
- Spearhead the preparation of annual budget, assumptions, and presentations to key stakeholders
- Key Achievements:
- Introduced process to simplify financial close and focus on the key story of the business performance.
Associate Finance Director
Global Cell Therapy (CAR-T) Franchise, Bristol Myers Squibb
, New Jersey
06.2022 - 04.2024
- Created 10-year long-range plan quantifying revenues of key assets in partnership with the Commercial team
- Built and released a rolling forecast revenue model to quantify quarterly sales estimates (+/- 3% error range)
- Developed and refined patient drop-off metrics for the revenue forecast (1-2% of revenue) with Supply Chain
- Simplified revenue recognition policies, it streamlined sales deferral & returns reserve (saved 4 human days)
- Key Achievements:
- Delivered commercial launches for Abecma & Breyanzi in France, Switzerland, Austria & Germany with aggregate sales valued at ~$100M
- Received the Innovation award for Product Profitability Standards Project and Urgency award – CART Budget Support in 2023 by President of Cell Therapy
- Led and established Revenue recognition rules for Outcome Based Agreements Markets in Europe.
Associate Finance Director
Global Commercial Financial, Analysis, Bristol Myers Squibb
, New Jersey
10.2018 - 06.2022
- Developed and presented a budget deck including revenue (by drivers/brand/market, showing CAGR, US and International mix), gross and operating margins, and resource allocation
- Oversaw the quarterly commercial roll-up of Sales and Opex (including drivers of variance by market and brands) to explain financial results to Commercial leadership
- Drove standardization of the quarterly financial package to deliver insights, clear stories, and visualizations
- Led the Product P&L project including cost allocation guidance and integration of Celgene product P&L
- Created and implemented a Cross Market Benchmarking tool to provide revenue growth and investment insights to finance leaders
- Headed complex Gross Margin analysis (Sales Mix, COGS & FX) for quarterly Investors Relations meetings
- Key Achievements:
- Delivered for EMAC HQ (Europe, Australia & Canada) project encompassing the acceleration of sales consolidation for corporate reporting (1/2-day vs one day)
- Identified risk areas through P&L Flux analysis as part of Internal Audit team (Guest Auditor) for BMS France
- Reduced market errors by 10%-15% by developing and implementing a model to automate COGS forecast
- Recognized with a variety of awards between 2018 and 2020 including:
- Passion Award - Hematology Finance Bex Training
- Urgency Award - BMS CFP&A and Celgene Integration | Finance Ops Budget Review
- Innovation Award - Commercialization Financial Dashboard | Standard COGS Forecasting Tool
- Accountability Award – Billing Currency Change Project and Budget Support
- Received 2021 CFO award for leadership in building the Product P&L ecosystem for Resource Allocation decision making.
Associate Director
A Center of Excellence, Bristol Myers Squibb
, New Jersey
02.2015 - 10.2018
- Spearheaded global FP&A process enhancements and simplification across the company
- Demystified complex COGS and FX topic by leading training sessions for finance teams (~120 attendees)
- Directed Parallel Trade compensation for markets in European Union (budget/projections for PT)
- Headed Regional Finance meeting for Middle East region in Dubai, UAE focusing on Region’s business drivers sharing FP&A CoE key highlights/vision, career opportunities, and identifying actionable plan for pain areas
- Led discussions between markets (US and Germany) for sharing best practice on hot topics such as tracking expense by indications for Oncology business
- Key Achievements:
- Improved P&L forecast by ~$224M by delivering the Global simplification initiative on foreign exchange
- Designed global commercial inventory revaluation process, improving enterprise forecasts by ~$258MM
- Determined market pain points and identified sustainable solutions that were system/process driven in collaboration with market Finance Directors and FP&A leads across the globe
- Strategically developed and implemented a complex process of Puerto Rico excise tax for commercial markets by training and simplifying forecast (impact approx
- 95M)
- Recognized with the Bravo award in 2017.
Senior Manager
Bristol Myers Squibb
Mumbai, India
07.2010 - 02.2015
- Oversaw the activities of a team of three creating budgets, partnering with the BU head to understand business assumptions, sales growth trends, resource allocations, and developing what-if scenarios
- Spearheaded pre-launch financial feasibility for Diabetes portfolio and post-launch sales trajectory monitoring for $9M in sales, while assessing the pricing and financial impacts of patient affordability program
- Cultivated Alliance relationships (AstraZeneca & Pfizer) for sharing data and forecasting assumptions
- Streamlined commercial policy i.e
- Credit terms, pricing, and discount structure through strategic collaboration
- Regularly monitored DSO and Receivables by channel (Trade: 38 days & Key Accounts: 90 days) vs targets
- Key Achievements:
- Led financial evaluation - Spyrcel India Patient Assistance Program ($16M), responding to patent infringement
- Setup an analytical framework by growing FP&A team, decision support models, and determining risks
- Analyzed working capital needs and collaborated with the global treasury team for capital infusion of $10M
- Fixed the optimal transfer price (incorporating direct/indirect tax risks) in partnership with corporate tax team
- Recognized as 2011 Employee of the Year
- Directed and planned onboarding of financial process for the newly recruited FP&A team in Thailand.
Deputy Manager
Vodafone
, India
10.2009 - 07.2010
Finance Analyst
Johnson & Johnson
, India
07.2007 - 10.2009
Education
Post Graduate Program - Data Analytics
Purdue University
01.2021
Business Analytics Certification (Online) -
The Wharton School
01.2019
Certified Management Accountant (CMA) / -
Institute of Management Accountants
01.2018
Chartered Accountant (CA) -
The Institute of Chartered Accountants of India
Bachelor of Commerce -
University of Mumbai
Skills
- Strategic Analysis
- Business Planning
- Relationship Development
- Regulatory Compliance
- Business Partnerships
- Data Analytics / Modelling
- Excellent Communication Skills
- Internal Controls/Systems
- Global Project Management
- Financial Management
- Policies & Procedures
- People Development
- SOFTWARE / VISUALIZATION & MODELLING SKILLS
- Microsoft Office Suite, Hyperion (Oracle-based), BPT (SAP based), SAP BW/BI, SAP/RPM, Python, R
- Highly skilled in building Scorecards, Dashboards & advanced Models using Excel, Power BI, and Tableau
Timeline
Associate Finance Director, Lead
Bristol Myers Squibb
04.2024 - Current
Associate Finance Director
Global Cell Therapy (CAR-T) Franchise, Bristol Myers Squibb
06.2022 - 04.2024
Associate Finance Director
Global Commercial Financial, Analysis, Bristol Myers Squibb
10.2018 - 06.2022
Associate Director
A Center of Excellence, Bristol Myers Squibb
02.2015 - 10.2018
Senior Manager
Bristol Myers Squibb
07.2010 - 02.2015
Deputy Manager
Vodafone
10.2009 - 07.2010
Finance Analyst
Johnson & Johnson
07.2007 - 10.2009
Post Graduate Program - Data Analytics
Purdue University
Business Analytics Certification (Online) -
The Wharton School
Certified Management Accountant (CMA) / -
Institute of Management Accountants
Chartered Accountant (CA) -
The Institute of Chartered Accountants of India
Bachelor of Commerce -
University of Mumbai
Similar Profiles
Siddharth SinghSiddharth Singh
Pharmaceutical Manufacturing Operator at Bristol Myers SquibbPharmaceutical Manufacturing Operator at Bristol Myers Squibb
Bria SpurlinBria Spurlin
QC Scientist at Bristol Myers SquibbQC Scientist at Bristol Myers Squibb
Eric J. HealyEric J. Healy
Operator 2 at Bristol Myers SquibbOperator 2 at Bristol Myers Squibb
GUSTAVO BRIONESGUSTAVO BRIONES
MATERIALS MANAGEMENT PLANNER at Bristol-Myers SquibbMATERIALS MANAGEMENT PLANNER at Bristol-Myers Squibb
Alexander PasqualeAlexander Pasquale
Freelance Filmmaker at Self-employedFreelance Filmmaker at Self-employed